Skip to content

Oxygen Therapy for Headache

Efficacy of Oxygen Therapy in Primary Headache Disorder

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05511155
Enrollment
132
Registered
2022-08-22
Start date
2022-07-01
Completion date
2022-09-30
Last updated
2022-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Headache Disorder

Keywords

oxygen therapy, migraine, emergency department, cluster type headache

Brief summary

Headache is one of the common causes of emergency department admissions and constitutes approximately 2%. Although the exact mechanism is not clear, It is known that high-flow oxygen therapy is effective in headache treatment. There are limited studies related to the use of oxygen therapy in headaches and its derivatives in the literature. In this study, the investigators aimed to compare the high and medium flow oxygen therapies with placebo in primary headache disorders.

Detailed description

Four different treatment methods were determined; 1) high-flow oxygen (15lt/min oxygen), 2) medium-flow oxygen (8lt/min oxygen), 3) high-flow room air as placebo (15 lt/min room air), 4) medium-flow room air as placebo (8 lt/min room air). All four treatment methods will be applied to all patients included in the study. One of the four treatments will be randomly applied at each separate ED admission with a gap of 1 week or more in between. This randomization will be performed by a computer at the time of admission. A study nurse will administer the patient's therapy according to the computer's current decision for 15 minutes. Patients and treating physicians will be blinded to the selected therapy. After 15 minutes of the end of treatment (at the 30th minute of the start of treatment), the treating physician will ask patients if they need rescue analgesia and analgesia will be administered if necessary. Additional analgesia is at the discretion of the treating physician. Patient data, including demographics, medical history, and findings of a physical examination performed before and after therapy will be recorded by the treating physician.

Interventions

OTHEROxygen therapy

Oxygen therapy will be given for 15 minutes with a non-rebreathing mask.

Sponsors

Aksaray University Training and Research Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* age 18-55 years * frequent attacks of primary headache disorders according to International Headache Society (IHS) criteria

Exclusion criteria

* secondary headache disorders * oxygen-dependent chronic illnesses such as chronic obstructive pulmonary disease * a history of cerebrovascular disease * pregnancy * active smokers or living with a smoker.

Design outcomes

Primary

MeasureTime frameDescription
visual analog scale score0-60 minutesprimary endpoint is the relative reduction in visual analog scale (a psychometric response scale) score in the placebo versus oxygen group to determine whether there was a difference between the high-flow and mid-flow therapies. visual analog scale scaled from 0-100 points with 0 meaning no pain and 100 points meaning worst possible pain.

Secondary

MeasureTime frameDescription
rescue analgesia30 th minutesrescue analgesia (yes/no)
length of stay0-300 minuteslength of stay in the emergency department (time in minutes)
duration of a pain0-300 minutesduration of a pain attack (time in minutes)
readmission0-7 daysreadmission to the emergency department within 7 days (yes/no)

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026